Ken Griffin Opko Health, Inc. Transaction History
Citadel Advisors LLC
- $509 Billion
- Q1 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Opko Health, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 495,600 shares of OPK stock, worth $619,500. This represents 0.0% of its overall portfolio holdings.
Number of Shares
495,600
Previous 207,400
138.96%
Holding current value
$619,500
Previous $313,000
89.78%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding OPK
# of Institutions
234Shares Held
155MCall Options Held
3.02MPut Options Held
888K-
Black Rock Inc. New York, NY33.2MShares$41.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.5MShares$36.9 Million0.0% of portfolio
-
State Street Corp Boston, MA10.2MShares$12.8 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA9.97MShares$12.5 Million0.0% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA5.81MShares$7.26 Million0.0% of portfolio
About OPKO HEALTH, INC.
- Ticker OPK
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 771,960,000
- Market Cap $965M
- Description
- OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and...